Cross-lineage single-cell and spatial analysis identifies an endothelial NF-kB-CCL2 axis coupled to myeloid IL1B in sarcoma and carcinoma
Abstract CCL2-CCR2 signaling recruits myeloid cells in cancer, but the CCL2-producing compartments and upstream inflammatory programs are usually studied within one tissue context. We integrated five human single-cell cohorts spanning UPS sarcoma, oral SCC, TNBC, colorectal cancer, and NSCLC; 12 Visium spatial samples; LIANA and CellChat communication analyses; patient-level pseudobulk meta-analysis; NicheNet inference; DepMap and PRISM screens; and external bulk validation in TCGA-SARC and GSE202361. CCL2 was produced mainly by fibroblast/CAF, endothelial, and myeloid cells, whereas malignant epithelial CCL2 positivity was low; UPS malignant mesenchymal cells showed higher CCL2 positivity, although this sarcoma comparison was small. CCR2 was sparse and concentrated in myeloid, B/plasma, and T/NK compartments. LIANA and CellChat supported fibroblast/CAF-to-myeloid and endothelial-to-myeloid CCL2-CCR2 axes across all five cohorts. Endothelial NFKB_TARGETS was the most stable patient-level program associated with CCL2 (pooled rho = 0.680, p = 0.00021, I2 = 0), and myeloid IL1B was the most consistent upstream candidate (rho = 0.452, p = 0.0335, I2 = 0). Spatial NF-kB-high regions were myeloid-enriched, but CCL2 was not axis-specific. External UPS cohorts supported NFKB_TARGETS-CCL2 and NFKB_TARGETS-IL1B associations, with attenuation of the CCL2 relationship after composition adjustment. These findings support a microenvironment model centered on myeloid IL1B, endothelial NF-kB, and CCL2 without establishing causality.
Authors
- Saiyang Li
Institutions
- Jiamusi University (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-11035851/v1
- Primary Topic
- Chemokine receptors and signaling
- Type
- preprint